Blood lossTime point: mean 48 hours, range 1 to 13 days. Higher blood loss indicates a worse outcome. · people undergoing total knee replacement
1 finding from 1 review
Physical function · systemic lupus erythematosus
1 finding from 1 review
Functional capacity · systemic lupus erythematosus
1 finding from 1 review
Physical function · systemic lupus erythematosus
1 finding from 1 review
QoL · children with juvenile idiopathic arthritis and flat feet
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
QoL · children with juvenile idiopathic arthritis and flat feet
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
QoL · children with juvenile idiopathic arthritis and flat feet
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
QoL · children with symptomatic flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Mobility · older people living in the community with frailty
1 finding from 1 review
Level of functioning · older people living in the community with frailty
2 findings from 1 review
Mobility · older people living in the community with frailty
2 findings from 1 review
Level of functioning · older people living in the community with frailty
1 finding from 1 review
Mobility · older people living in the community with frailty
1 finding from 1 review
Level of functioning · older people living in the community with frailty
1 finding from 1 review
Skin thickness – mRSS Scale 0–51 in which a higher number is worse skin thickening · people with systemic sclerosis
Autologous myeloablative selective HSCT probably leads to higher skin thickness – mRSS Scale 0–51 in which a higher number is worse… compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Skin thickness – mRSS Scale 0–51 in which a higher number is worse skin thickening · people with systemic sclerosis
1 finding from 1 review
Skin thickness – mRSS Scale 0–51 in which a higher number is worse skin thickening · people with systemic sclerosis
1 finding from 1 review
Function Various validated function scales. · Patients with shoulder pain
1 finding from 1 review
Mean change in quality of life at ≥ 12 months using the 36‐Item Short Form Health Survey mental component score (SF‐36 MCS) · Patients with shoulder pain
1 finding from 1 review
Reduction of at least 4 points in SELENA‐SLEDAI at 52 weeks SELENA‐SLEDAI score, a validated marker of SLE disease activity (range 0 to 105; higher score = worse disease activity) · people with active systemic lupus erythematosus (but not active nephritis or active central nervous system involvement)
Belimumab 10 mg/kg leads to higher reduction of at least 4 points in SELENA‐SLEDAI at 52 weeks… compared with placebo (high certainty).
1 finding from 1 review